SG Americas Securities’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-85,649
Closed -$217K 3595
2023
Q4
$217K Buy
85,649
+16,437
+24% +$38.3K ﹤0.01% 2094
2023
Q3
$165K Buy
69,212
+55,626
+409% +$123K ﹤0.01% 2428
2023
Q2
$31K Sell
13,586
-46,420
-77% -$131K ﹤0.01% 2162
2023
Q1
$153K Sell
60,006
-39,036
-39% -$112K ﹤0.01% 2628
2022
Q4
$249K Sell
99,042
-8,698
-8% -$24.3K ﹤0.01% 2053
2022
Q3
$312K Buy
107,740
+39,112
+57% +$165K ﹤0.01% 1957
2022
Q2
$310K Buy
+68,628
New +$408K ﹤0.01% 2361

SG Americas Securities's SLGC Position: Q1 2024 in Review

SG Americas Securities sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 85,649 shares — an estimated $217K sold.

SG Americas Securities first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $312K in Q3 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • SG Americas Securities reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 85,649 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $217K.
  • SG Americas Securities first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
  • SG Americas Securities's SomaLogic, Inc. Class A Common Stock position peaked at $312K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.